Supernus Pharmaceuticals Inc (SUPN) Stock Price, Quote, News & History

SUPNNASDAQ
$47.85
-0.15-0.31%
At close: May 1, 5:00 PM EST
$47.85
N/A
After Hours: May 1, 4:37 PM EST
Earnings: Q1 2026 earnings tomorrow on Tue May 5th after the market close
Conference Call: Conference call scheduled tomorrow at 4:30 PM
Click to view the webcast
Loading...

Key Statistics

Open
$48.02
Close
$47.85
Volume / Avg.
622.23K / 691.30K
Day Range
$47.17 - $48.33
52 Wk Range
29.16 - 59.68
Market Cap
$2.67B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
38
Short Interest
12.83%
Days to Cover
9.31

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
47.33M
Investing Cash Flow (TTM)
4.11M
Financing Cash Flow (TTM)
9.13M
Free Cash Flow (TTM)
45.99M
Capital Expenditure (TTM)
-1.34M
Net Change in Cash (TTM)
60.57M

Analyst Trends and Forecast

0
0
0
0
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.49B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.77
PB Ratio (TTM)
2.60
Earnings Yield % (TTM)
-1.42%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
58.68
Price / EBITDA (TTM)
63.69
Price / Free Cash Flow (TTM)
58.90
Book Value / Share
$18.44

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
$0
Total Cash
$128.45M
Debt to Equity
0.04
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$48.02
Close
$47.85
Volume / Avg.
622.23K / 691.30K
Day Range
$47.17 - $48.33
52 Wk Range
29.16 - 59.68
Market Cap
$2.67B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
38
Short Interest
12.83%
Days to Cover
9.31

About

Sector
Health Care
Industry
Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Supernus Pharmaceuticals (SUPN) stock?

A

You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Supernus Pharmaceuticals (SUPN) competitors?

Q

What is the forecast, or price target, for Supernus Pharmaceuticals (SUPN) stock?

A

Supernus Pharmaceuticals has a consensus price target of $61.60.

Q

What is the current price for Supernus Pharmaceuticals (SUPN)?

A

The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $47.85 last updated May 1, 2026 at 4:37 PM EDT.

Q

Does Supernus Pharmaceuticals (SUPN) pay a dividend?

A

There are no upcoming dividends for Supernus Pharmaceuticals.

Q

When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?

A

Supernus Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Supernus Pharmaceuticals (SUPN) going to split?

A

There is no upcoming split for Supernus Pharmaceuticals.

Q

What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?

A

Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.